J&J Prices Consumer Unit IPO at $22 a Share

Listing of Tylenol maker would be by far the biggest IPO so far this year

Sales of Tylenol were driven higher by a rough cold and flu season. Photo: gary cameron/Reuters

Johnson & Johnson’s big consumer-healthcare business priced its initial public offering at $22 a share in the biggest new-stock listing of the year.

The offering was priced at the higher end of the $20 to $23 targeted range, with about 10% more shares sold than planned, according to people familiar with the matter. At that price, the offering is expected to raise at least $3.7 billion and value the new company, known as Kenvue, at more than $40 billion. 

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • Kohl's:
    Kohl's promo code: 30% Off for Kohl's Rewards Members
  • Walmart:
    20% off your order with Walmart promo code
  • Target:
    Target Promo Code: 20% Off Entire Order
  • Newegg:
    10% Off Sitewide - Newegg Promo Code
  • Dell:
    Redeem 35% off your cart with Dell coupon code
  • Best Buy:
    Deal of the Day! Claim as much as 50% Off - Best Buy Coupon